142 related articles for article (PubMed ID: 9158509)
21. Bladder tumours in Chinese: a 6 year study.
Lam KY; Chan AC; Chan KW
Aust N Z J Surg; 1994 Aug; 64(8):551-5. PubMed ID: 8048894
[TBL] [Abstract][Full Text] [Related]
22. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
23. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
[TBL] [Abstract][Full Text] [Related]
24. Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
Supit W; Mochtar CA; Sugiono M; Umbas R
Asian Pac J Cancer Prev; 2011; 12(2):549-53. PubMed ID: 21545228
[TBL] [Abstract][Full Text] [Related]
25. BCG in management of transitional cell carcinoma invasive to prostate.
Siami P; Chinn S; Clayton M; Ray V; Rubenstein M; Guinan P
Urology; 1989 Dec; 34(6):381-2. PubMed ID: 2595884
[TBL] [Abstract][Full Text] [Related]
26. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
28. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
[TBL] [Abstract][Full Text] [Related]
30. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
31. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
Goonewardena SA; De Silva WA; De Silva MV
Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
[TBL] [Abstract][Full Text] [Related]
32. Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
Jahnson S; Hosseini Aliabad A; Holmäng S; Jancke G; Liedberg F; Ljungberg B; Malmström PU; Rosell J
Scand J Urol; 2016; 50(1):14-20. PubMed ID: 26382667
[TBL] [Abstract][Full Text] [Related]
33. [T1G3 transitional cell carcinoma of the bladder: our experience with 44 patients treated with intravesical BCG after TUR].
Hurle R; Graziotti P; Ranieri A; Losa A; Micheli E; Lembo A
Arch Ital Urol Androl; 1996 Feb; 68(1):13-6. PubMed ID: 8664913
[TBL] [Abstract][Full Text] [Related]
34. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases.
Amin MB; Gómez JA; Young RH
Am J Surg Pathol; 1997 Sep; 21(9):1057-68. PubMed ID: 9298882
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
36. Upper tract tumours in patients with vesico-ureteral reflux and recurrent bladder tumours.
Mukamel E; Nissenkorn I; Glanz I; Vilcovsky E; Servadio C
Eur Urol; 1985; 11(1):6-8. PubMed ID: 3987750
[TBL] [Abstract][Full Text] [Related]
37. Conservative treatment of high grade superficial bladder tumours.
Trinchieri A; Bonacina P; Butti A; Cappoli S; Esposito N; Invernizzi S; Librizzi A; Locatelli G
Arch Ital Urol Androl; 2005 Dec; 77(4):215-8. PubMed ID: 16444936
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.
Stewart GD; Bariol SV; Grigor KM; Tolley DA; McNeill SA
BJU Int; 2005 Apr; 95(6):791-3. PubMed ID: 15794784
[TBL] [Abstract][Full Text] [Related]
39. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
[TBL] [Abstract][Full Text] [Related]
40. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
